Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 188

    1.

    Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.

    Pfützner A, Kunt T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Forst T.

    Diabetes Care. 2004 Mar;27(3):682-7.PMID: 14988285 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    IRIS II Study: Sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistance.

    Langenfeld MR, Forst T, Standl E, Strotmann HJ, Lübben G, Pahler S, Kann P, Pfützner A; IRIS II study.

    Diabetes Technol Ther. 2004 Dec;6(6):836-43.PMID: 15684637 [PubMed - indexed for MEDLINE]Related articles

    3.

    IRIS II study: intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study design.

    Pfützner A, Standl E, Hohberg C, Konrad T, Strotmann HJ, Lübben G, Langenfeld MR, Schulze J, Forst T.

    Diabetes Technol Ther. 2005 Jun;7(3):478-86.PMID: 15929679 [PubMed - indexed for MEDLINE]Related articles

    4.

    Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.

    Pfützner A, Langenfeld M, Kunt T, Löbig M, Forst T.

    Clin Lab. 2003;49(11-12):571-6.PMID: 14651328 [PubMed - indexed for MEDLINE]Related articles

    5.

    Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.

    Pfützner A, Schöndorf T, Seidel D, Winkler K, Matthaei S, Hamann A, Forst T.

    Metabolism. 2006 Jan;55(1):20-5.PMID: 16324915 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.

    Pfützner A, Kann PH, Pfützner AH, Kunt T, Larbig M, Weber MM, Forst T.

    Clin Lab. 2004;50(9-10):567-73. Review.PMID: 15481632 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Use of proinsulin analysis for estimates of insulin resistance]

    Stejskal D, Pastorková R, Bartek J, Růzicka V, Horalík D.

    Vnitr Lek. 1999 Feb;45(2):110-4. Czech. PMID: 15641230 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes.

    Nagi DK, Knowler WC, Mohamed-Ali V, Bennett PH, Yudkin JS.

    Diabetes Care. 1998 Jan;21(1):127-33.PMID: 9538983 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Clinical and laboratory evaluation of a new specific ELISA for intact proinsulin.

    Pfützner A, Pfützner AH, Kann PH, Stute R, Löbig M, Yang JW, Mistry J, Forst T.

    Clin Lab. 2005;51(5-6):243-9.PMID: 15991797 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.

    Røder ME, Dinesen B, Hartling SG, Houssa P, Vestergaard H, Sodoyez-Goffaux F, Binder C.

    Diabetes Care. 1999 Apr;22(4):609-14.PMID: 10189540 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: an 11-year follow-up of the Hoorn Study.

    Alssema M, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ; Hoorn Study.

    Diabetes Care. 2005 Apr;28(4):860-5.PMID: 15793186 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study.

    Mykkänen L, Zaccaro DJ, Hales CN, Festa A, Haffner SM.

    Diabetologia. 1999 Sep;42(9):1060-6.PMID: 10447516 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Current laboratory parameters in the differential diagnosis of type 2 diabetes mellitus. Proinsulin, adiponectin and others]

    Forst T, Pfützner A.

    Dtsch Med Wochenschr. 2006 Dec;131 Suppl 8:S268-73. Review. German. PMID: 17139585 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.

    Pradhan AD, Manson JE, Meigs JB, Rifai N, Buring JE, Liu S, Ridker PM.

    Am J Med. 2003 Apr 15;114(6):438-44.PMID: 12727576 [PubMed - indexed for MEDLINE]Related articles

    16.

    Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.

    Al-Harithy RN, Al-Ghamdi S.

    Ann Saudi Med. 2005 Jul-Aug;25(4):283-7.PMID: 16212119 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects.

    Matsuhisa M, Yamasaki Y, Emoto M, Shimabukuro M, Ueda S, Funahashi T, Matsuzawa Y.

    Diabetes Res Clin Pract. 2007 Jul;77(1):151-4. Epub 2006 Nov 1. Erratum in: Diabetes Res Clin Pract. 2007 Sep;77(3):496. Ueda, Shinichiro [added]. PMID: 17081646 [PubMed - indexed for MEDLINE]Related articles

    19.

    Fasting proinsulin concentrations predict the development of type 2 diabetes.

    Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN.

    Diabetes Care. 1999 Feb;22(2):262-70.PMID: 10333943 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

    Osei K, Gaillard T, Schuster D.

    Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data